These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36636832)

  • 1. First-in-human application of double-stranded RNA bacteriophage in the treatment of pulmonary Pseudomonas aeruginosa infection.
    Li L; Zhong Q; Zhao Y; Bao J; Liu B; Zhong Z; Wang J; Yang L; Zhang T; Cheng M; Wu N; Zhu T; Le S
    Microb Biotechnol; 2023 Apr; 16(4):862-867. PubMed ID: 36636832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the first double-stranded RNA bacteriophage infecting Pseudomonas aeruginosa.
    Yang Y; Lu S; Shen W; Zhao X; Shen M; Tan Y; Li G; Li M; Wang J; Hu F; Le S
    Sci Rep; 2016 Dec; 6():38795. PubMed ID: 27934909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
    Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C
    mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Innate Immune Susceptibility in Hyperpigmented Bacteriophage-Resistant Mutants of Pseudomonas aeruginosa.
    Menon ND; Penziner S; Montaño ET; Zurich R; Pride DT; Nair BG; Kumar GB; Nizet V
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0023922. PubMed ID: 35862755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel N4-Like Bacteriophage Isolated from a Wastewater Source in South India with Activity against Several Multidrug-Resistant Clinical Pseudomonas aeruginosa Isolates.
    Menon ND; Kumar MS; Satheesh Babu TG; Bose S; Vijayakumar G; Baswe M; Chatterjee M; D'Silva JR; Shetty K; Haripriyan J; Kumar A; Nair S; Somanath P; Nair BG; Nizet V; Kumar GB
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomic Analysis Reveals the Dependency of
    Zhong Q; Yang L; Li L; Shen W; Li Y; Xu H; Zhong Z; Chen M; Le S
    iScience; 2020 Sep; 23(9):101437. PubMed ID: 32827855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
    Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
    AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance, mechanism, and fitness cost of specific bacteriophages for
    Feng L; Chen H; Qian C; Zhao Y; Wang W; Liu Y; Xu M; Cao J; Zhou T; Wu Q
    mSphere; 2024 Feb; 9(2):e0055323. PubMed ID: 38299825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa.
    Köhler T; Luscher A; Falconnet L; Resch G; McBride R; Mai QA; Simonin JL; Chanson M; Maco B; Galiotto R; Riat A; Civic N; Docquier M; McCallin S; Chan B; van Delden C
    Nat Commun; 2023 Jun; 14(1):3629. PubMed ID: 37369702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.
    Jault P; Leclerc T; Jennes S; Pirnay JP; Que YA; Resch G; Rousseau AF; Ravat F; Carsin H; Le Floch R; Schaal JV; Soler C; Fevre C; Arnaud I; Bretaudeau L; Gabard J
    Lancet Infect Dis; 2019 Jan; 19(1):35-45. PubMed ID: 30292481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting lung adaptation and phage steering to clear pan-resistant Pseudomonas aeruginosa infections in vivo.
    Ashworth EA; Wright RCT; Shears RK; Wong JKL; Hassan A; Hall JPJ; Kadioglu A; Fothergill JL
    Nat Commun; 2024 Feb; 15(1):1547. PubMed ID: 38378698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation.
    Chang RYK; Chen K; Wang J; Wallin M; Britton W; Morales S; Kutter E; Li J; Chan HK
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy.
    Wright A; Hawkins CH; Anggård EE; Harper DR
    Clin Otolaryngol; 2009 Aug; 34(4):349-57. PubMed ID: 19673983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophage Therapy Increases Complement-Mediated Lysis of Bacteria and Enhances Bacterial Clearance After Acute Lung Infection With Multidrug-Resistant Pseudomonas aeruginosa.
    Abd El-Aziz AM; Elgaml A; Ali YM
    J Infect Dis; 2019 Apr; 219(9):1439-1447. PubMed ID: 30476337
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Aslam S; Roach D; Nikolich MP; Biswas B; Schooley RT; Lilly-Bishop KA; Rice GK; Cer RZ; Hamilton T; Henry M; Luong T; Salabarria A-C; Sisk-Hackworth L; Filippov AA; Lebreton F; Hall L; Nir-Paz R; Onallah H; Livni G; Shostak E; Wieder-Finesod A; Yahav D; Yerushalmy O; Alkalay-Oren S; Braunstein R; Khalifa L; Rimon A; Gelman D; Hazan R
    Antimicrob Agents Chemother; 2024 Apr; 68(4):e0172823. PubMed ID: 38470133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Host Immune Response to Bacteriophage in a Lung Transplant Recipient on Adjunctive Phage Therapy for a Multidrug-Resistant Pneumonia.
    Dan JM; Lehman SM; Al-Kolla R; Penziner S; Afshar K; Yung G; Golts E; Law N; Logan C; Kovach Z; Mearns G; Schooley RT; Aslam S; Crotty S
    J Infect Dis; 2023 Feb; 227(3):311-316. PubMed ID: 36082999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of JG024, a pseudomonas aeruginosa PB1-like broad host range phage under simulated infection conditions.
    Garbe J; Wesche A; Bunk B; Kazmierczak M; Selezska K; Rohde C; Sikorski J; Rohde M; Jahn D; Schobert M
    BMC Microbiol; 2010 Nov; 10():301. PubMed ID: 21110836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Novel Bacteriophages Improve Survival in
    Jeon J; Yong D
    Appl Environ Microbiol; 2019 May; 85(9):. PubMed ID: 30824445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial Activity of a Lytic Enzyme Encoded by
    Yang Y; Le S; Shen W; Chen Q; Huang Y; Lu S; Tan Y; Li M; Hu F; Li Y
    Front Microbiol; 2018; 9():1778. PubMed ID: 30127777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
    Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
    Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.